TFS Capital’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-9,284
Closed -$589K 1820
2013
Q3
$589K Buy
+9,284
New +$589K 0.03% 797